MEDP - Medpace Holdings, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
61.31
+0.99 (+1.64%)
At close: 4:00PM EST

61.31 0.00 (0.00%)
After hours: 4:34PM EST

Stock chart is not supported by your current browser
Previous Close60.32
Open60.08
Bid45.00 x 800
Ask61.87 x 800
Day's Range59.73 - 61.36
52 Week Range31.75 - 65.09
Volume596,401
Avg. Volume717,317
Market Cap2.17B
Beta (3Y Monthly)1.62
PE Ratio (TTM)37.16
EPS (TTM)1.65
Earnings DateOct 29, 2018 - Nov 2, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est59.40
Trade prices are not sourced from all markets
  • Markit12 hours ago

    See what the IHS Markit Score report has to say about Medpace Holdings Inc.

    # Medpace Holdings Inc ### NASDAQ/NGS:MEDP View full report here! ## Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is moderate and increasing ## Bearish sentiment Short interest | Negative Short interest is moderately high for MEDP with between 10 and 15% of shares outstanding currently on loan. This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on January 4. ## Money flow ETF/Index ownership | Negative ETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding MEDP totaled $1.13 billion. Additionally, the rate of outflows appears to be accelerating. ## Economic sentiment PMI by IHS Markit | Neutral According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, but is easing. ## Credit worthiness Credit default swap CDS data is not available for this security. Please send all inquiries related to the report to score@ihsmarkit.com. Charts and report PDFs will only be available for 30 days after publishing. This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Markit9 days ago

    See what the IHS Markit Score report has to say about Medpace Holdings Inc.

    # Medpace Holdings Inc ### NASDAQ/NGS:MEDP View full report here! ## Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is moderate and increasing * Economic output in this company's sector is expanding ## Bearish sentiment Short interest | Negative Short interest is moderately high for MEDP with between 10 and 15% of shares outstanding currently on loan. This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on January 4. ## Money flow ETF/Index ownership | Positive ETF activity is positive. Over the last month, ETFs holding MEDP are favorable, with net inflows of $2.83 billion. Additionally, the rate of inflows is increasing. ## Economic sentiment PMI by IHS Markit | Positive According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year. ## Credit worthiness Credit default swap CDS data is not available for this security. Please send all inquiries related to the report to score@ihsmarkit.com. Charts and report PDFs will only be available for 30 days after publishing. This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Look Before You Leap: Using Test Trades In A Rally
    Investor's Business Daily13 days ago

    Look Before You Leap: Using Test Trades In A Rally

    It is still too early to tell whether the stock market correction is over. Test trades with a half position on swing trades are useful in that regard.

  • What's in Store for Teladoc in 2019, After a Strong 2018?
    Zacks20 days ago

    What's in Store for Teladoc in 2019, After a Strong 2018?

    Teladoc (TDOC) should continue to gain from increasing demand for its services and global expansion.

  • Cigna Poised for Growth in 2019 on Express Scripts Buyout
    Zacks20 days ago

    Cigna Poised for Growth in 2019 on Express Scripts Buyout

    The purchase of Express Scripts by Cigna (CI) has diversified its business, which should fuel long-term growth.

  • Why This IBD Stock Of The Day 'Continues To Push For New Highs'
    Investor's Business Daily21 days ago

    Why This IBD Stock Of The Day 'Continues To Push For New Highs'

    Medpace Holdings is the IBD Stock Of The Day as shares consolidate and its relative strength line approaches recent highs. Medpace Holdings stock is expected to break out at 65.19.

  • MEDP or HQY: Which Is the Better Value Stock Right Now?
    Zacks21 days ago

    MEDP or HQY: Which Is the Better Value Stock Right Now?

    MEDP vs. HQY: Which Stock Is the Better Value Option?

  • These Cincinnati stocks benefited most from market’s massive rally
    American City Business Journals22 days ago

    These Cincinnati stocks benefited most from market’s massive rally

    Following their worst-ever Christmas Eve on Monday, stocks staged a comeback on Wednesday with the Dow posting its largest daily point gain ever, and Cincinnati stocks weren’t left out of the boost.

  • Cincinnati health care firm joins S&P index
    American City Business Journals24 days ago

    Cincinnati health care firm joins S&P index

    Medpace Holdings Inc. will become part of a Standard & Poor’s stock market index before the open of trading on Jan. 2. Madisonville-based Medpace (Nasdaq: MEDP), which conducts clinical trials for companies worldwide that want to bring new drugs and medical devices to market, will be added to the S&P SmallCap 600’s health care sector under the Life Sciences Tools & Services sub-industry index.

  • Markit28 days ago

    See what the IHS Markit Score report has to say about Medpace Holdings Inc.

    # Medpace Holdings Inc ### NASDAQ/NGS:MEDP View full report here! ## Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low * Economic output in this company's sector is expanding ## Bearish sentiment Short interest | Positive Short interest is low for MEDP with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. ## Money flow ETF/Index ownership | Positive ETF activity is positive. Over the last month, ETFs holding MEDP are favorable, with net inflows of $1.29 billion. Additionally, the rate of inflows is increasing. ## Economic sentiment PMI by IHS Markit | Positive According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year. ## Credit worthiness Credit default swap CDS data is not available for this security. Please send all inquiries related to the report to score@ihsmarkit.com. Charts and report PDFs will only be available for 30 days after publishing. This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • The Zacks Analyst Blog Highlights: Anthem, Ensign, NeoGenomics, Merit Medical Systems and Medpace
    Zackslast month

    The Zacks Analyst Blog Highlights: Anthem, Ensign, NeoGenomics, Merit Medical Systems and Medpace

    The Zacks Analyst Blog Highlights: Anthem, Ensign, NeoGenomics, Merit Medical Systems and Medpace

  • Zackslast month

    5 Healthcare Bets to Stay in Investors Good Books Next Year

    Based on a few key factors, we zero in on five stocks that show promise to retain the bull run in 2019.

  • Markitlast month

    See what the IHS Markit Score report has to say about Medpace Holdings Inc.

    # Medpace Holdings Inc ### NASDAQ/NGS:MEDP Score: Neutral (46) 1 day at current score. Upgraded from Negative on December 13th 2018 View full report here! ## Summary * This company ranked positively in all 3 IHS Markit categories but was neutral compared to the Healthcare sector * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low * Economic output in this company's sector is expanding ## Bearish sentiment Short interest | Positive Short interest is low for MEDP with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. ## Money flow ETF/Index ownership | Neutral ETF activity is neutral. ETFs that hold MEDP had net inflows of $628 million over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. ## Economic sentiment PMI by IHS Markit | Positive According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year. ## Credit worthiness Credit default swap CDS data is not available for this security. Please send all inquiries related to the report to score@ihsmarkit.com. Charts and report PDFs will only be available for 30 days after publishing. This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Hedge Funds Are Crazy About Medpace Holdings, Inc. (MEDP)
    Insider Monkeylast month

    Hedge Funds Are Crazy About Medpace Holdings, Inc. (MEDP)

    Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue chips. That outperformance comes with a price, however, as there are occasional periods of higher volatility. The one and a half month time period since the end of the […]

  • Teladoc (TDOC) Surges 64% in a Year: Can the Rally Continue?
    Zackslast month

    Teladoc (TDOC) Surges 64% in a Year: Can the Rally Continue?

    Teladoc (TDOC) is poised to grow on accelerating demand for its telehealth services.

  • PRA Health Sciences (PRAH) Hits Fresh High: Is There Still Room to Run?
    Zacks2 months ago

    PRA Health Sciences (PRAH) Hits Fresh High: Is There Still Room to Run?

    PRA Health Sciences (PRAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

  • BioTelemetry (BEAT) Soars to 52-Week High, Time to Cash Out?
    Zacks2 months ago

    BioTelemetry (BEAT) Soars to 52-Week High, Time to Cash Out?

    BioTelemetry (BEAT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

  • IBD 50 Stock Breaks Out Amid Boost For Medical Research Stocks
    Investor's Business Daily2 months ago

    IBD 50 Stock Breaks Out Amid Boost For Medical Research Stocks

    PRA Health stock broke out Thursday amid a broad boost for medical research stocks. Medical research stocks are benefiting from inflows into biotechs.

  • MEDP vs. PRAH: Which Stock Should Value Investors Buy Now?
    Zacks2 months ago

    MEDP vs. PRAH: Which Stock Should Value Investors Buy Now?

    MEDP vs. PRAH: Which Stock Is the Better Value Option?

  • IBD 50 Stocks To Watch: Unlike The Market, This Top Stock Is On Win Streak
    Investor's Business Daily2 months ago

    IBD 50 Stocks To Watch: Unlike The Market, This Top Stock Is On Win Streak

    Many growth stocks have gotten hurt as the market turned south during the past week. But Medpace Holdings is showing unusual strength.

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of MEDP earnings conference call or presentation 30-Oct-18 1:00pm GMT

    Q3 2018 Medpace Holdings Inc Earnings Call

  • Simply Wall St.2 months ago

    How Does Medpace Holdings Inc (NASDAQ:MEDP) Affect Your Portfolio Volatility?

    Anyone researching Medpace Holdings Inc (NASDAQ:MEDP) might want to consider the historical volatility of the share price. Volatility is considered to be a measure of risk in modern finance theory. Read More...

  • Business Wire3 months ago

    Medpace Holdings, Inc. to Present at Credit Suisse Healthcare Conference

    Medpace Holdings, Inc. today announced that it will present at the following investor conference in November:

  • MEDP vs. PRAH: Which Stock Is the Better Value Option?
    Zacks3 months ago

    MEDP vs. PRAH: Which Stock Is the Better Value Option?

    MEDP vs. PRAH: Which Stock Is the Better Value Option?